Metabolomic Profiles of Scleroderma-PAH are different than idiopathic PAH and associated with worse clinical outcomes
Mona Alotaibi, Junzhe Shao, Michael W. Pauciulo, William C. Nichols, Anna R. Hemnes, Atul Malhotra, Nick H. Kim, Jason X.-J. Yuan, Timothy Fernandes, Kim M. Kerr, Laith Alshawabkeh, Ankit A. Desai, Jeramie D. Watrous, Susan Cheng, Tao Long, Stephen Y. Chan, Mohit Jain
medRxiv 2021.07.10.21259355; doi: https://doi.org/10.1101/2021.07.10.21259355